2-(3,5-Dimethyl-7-oxo-7H-furo[3,2-g]chromen-6-yl)-N-(2,3,4,9-tetrahydro-1H-carbazol-1-yl)acetamide

Catalog No. :
ACEYUZ653
CAS No. :
2108851-35-8
Molecular Formula :
C27H24N2O4
Molecular Weight :
440.50

IUPAC Name:2-(3,5-dimethyl-7-oxo-7H-furo[3,2-g]chromen-6-yl)-N-(2,3,4,9-tetrahydro-1H-carbazol-1-yl)acetamide

2-(3,5-Dimethyl-7-oxo-7H-furo[3,2-g]chromen-6-yl)-N-(2,3,4,9-tetrahydro-1H-carbazol-1-yl)acetamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(3,5-Dimethyl-7-oxo-7H-furo[3,2-g]chromen-6-yl)-N-(2,3,4,9-tetrahydro-1H-carbazol-1-yl)acetamide
IUPAC Name2-(3,5-dimethyl-7-oxo-7H-furo[3,2-g]chromen-6-yl)-N-(2,3,4,9-tetrahydro-1H-carbazol-1-yl)acetamide
Molecular FormulaC27H24N2O4
Molecular Weight440.50
SMILESCC1=COC(C=C2O3)=C1C=C2C(C)=C(CC(NC4CCCC5=C4NC6=C5C=CC=C6)=O)C3=O
InChI KeyBYXLYSBHLIPJKU-UHFFFAOYSA-N
Synonym7H-Furo[3,2-g][1]benzopyran-6-acetamide, 3,5-dimethyl-7-oxo-N-(2,3,4,9-tetrahydro-1H-carbazol-1-yl)-
CAS No.2108851-35-8

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACEYUZ653 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACMHCT698 route compound structure diagram
    ACMHCT698118498-95-6 In Stock
  4. Then
  5. ACEYUZ653 route product structure diagram
    ACEYUZ6532108851-35-8
Inquiry

2. ACEYUZ653 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACEYUZ653 route product structure diagram
    ACEYUZ6532108851-35-8
Inquiry

Comments (0)